SMPaeds2 aims to advance precision medicines for children with relapsed cancer Cancer Research UK (CRUK) and Children with Cancer UK have announced […]
New trial to test VMX-C001’s effectiveness in restoring coagulation in FXa DOAC patients Biotech company VarmX has received clearance from the US FDA to begin […]
The update is aimed at strengthening local and national surveillance The UK Health Security Agency (UKHSA) has announced that it has expanded the list of […]